DOW JONES22,241.94+1189.41 5.65%
S&P 5002,626.96+138.31 5.56%
NASDAQ7,782.18+409.10 5.55%

Citigroup Initiates Coverage On Sage Therapeutics with Buy Rating, Announces $71 Price Target

Citigroup analyst Neena Bitritto-Garg initiates coverage on Sage Therapeutics (NASDAQ:SAGE) with a Buy rating and a $71 price target.

Benzinga · 03/06/2020 10:06

Citigroup analyst Neena Bitritto-Garg initiates coverage on Sage Therapeutics (NASDAQ:SAGE) with a Buy rating and a $71 price target.